The program is jointly staffed by physicians in Pediatric Nephrology and Pediatric Rheumatology at C.S. Mott Children's Hospital. We use an interdisciplinary approach to evaluate and treat all children with these combined diseases, offering them access to the latest treatments and clinical trials.

We specialize in lupus with lupus nephritis and diseases of blood vessel inflammation (vasculitis) that affect the kidney, such as:

• Systemic lupus erythematosus with lupus nephritis – an autoimmune disease that affects multiple organs, often presenting with malar rash, arthritis, and kidney involvement
• Granulomatosis with polyangiitis – small-medium blood vessel vasculitis that typically affects lungs and kidneys
• IgA vasculitis (formerly known as Henoch-Schoenlein purpura) – small-medium blood vessel vasculitis typically affecting skin, kidneys, joints, and gut

We also co-manage side effects of treatments for other diseases, including children with primary rheumatologic diseases who develop high blood pressure.

Patients are seen in the Interdisciplinary Systemic Inflammation clinic, which meets on the 2nd Thursday of each month. Patients are jointly seen by pediatric rheumatology and nephrology providers, as well as other care team members including pediatric psychology, social work, and nursing, to form a complete assessment and management plan.

Schedule an appointment by calling us at 734-764-2224.

The University of Michigan Health lupus research group is dedicated to learning more about what causes lupus, how flares can be reduced or prevented, how to predict disease progression and activity, and how to prevent permanent organ damage. By learning more about the development of and risk factors for lupus it may be a step towards finding new prevention and treatment strategies. Clinical trials are available for eligible patients, including investigational drug therapies.